Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA approves Erbitux to treat late-stage head and neck cancer

The U.S. Food and Drug Administration today approved Erbitux ( cetuximab ) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.

REFINE

medications
- - (-) Remove Erbitux filter Erbitux
conditions
- - Cancer (1) Apply Cancer filter
    Esophageal Cancer (1) Apply Esophageal Cancer filter
    
    Nasal Cancer (1) Apply Nasal Cancer filter
    
    Oral Cancer (1) Apply Oral Cancer filter
    
    Thyroid Cancer (1) Apply Thyroid Cancer filter